Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Diagnostics

Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA

A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
Diagnostics

Early Diagnostic Blood Biomarker for Dementia Identified Using Proteomics

The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.
Diagnostics

Investigating Biases in Diagnostics and Biomarkers: Three Case Studies

In the quest to improve diagnostics, new technologies are key, but so is overcoming entrenched bias.
Diagnostics

Machine Learning Metabolomics Approach Used to Diagnose Ovarian Cancer

Researchers have used an artificial intelligence model to analyse the metabolites of patients with or without ovarian cancer and have reported shocking accuracy of diagnosis.
Diagnostics

Using Biosensors for Biomarker Identification and Validation in Lung Cancer

Advancements in biosensors, notably graphene-based ones, show promise in swiftly identifying elusive lung cancer biomarkers, potentially revolutionising early diagnosis.
Diagnostics

Dynamic Biomarkers for Deep Immune Phenotyping in Autoimmune Disease

On-Demand Webinar featuring Dr Mo Jain, Founder & CEO of Sapient & Dr Tanya Nguyen, Head of Scientific Operations of Sapient
Diagnostics

A Wearable Ultrasound Patch for the Home Detection of Breast Cancer

Researchers from MIT have developed a wearable ultrasound patch that can image breast tissue, potentially facilitating the home detection of breast cancer. The patch can be attached a bra, and shows promise in detecting small cysts.
Diagnostics

Plasma Biomarkers Show Promise in CNS Trials for Alzheimer's Disease

Proteins in the brain and plasma of individuals with sporadic Alzheimer’s disease are altered, supporting the hypothesis that plasma biomarkers have utility in predicting early onset in cognitively unimpaired populations.
Diagnostics

ddPCR Approaches for Biomarker Detection and Analysis

The high sensitivity and specificity of ddPCR assays makes the approach well-suited for screening diseases and diagnosing cancer subtypes. Here, we explore some of the ways in which medical researchers are using the technology to pioneer detection of circulating biomarkers for liquid biopsies.
Diagnostics

Blood-Based Biomarkers and Liquid Biopsies in Cancer Treatment: Precision Oncology Approaches and Strategies

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer prognosis and treatment prediction.
Diagnostics

High Sensitivity Phenotyping of Extracellular Vesicles by Customized, Single-Molecule Assays

On-Demand Webinar featuring Marina Cretich, Senior Researcher of the National Research Council of Italy at SCITEC-CNR
Diagnostics

Emergency Use Authorization Issued by FDA for Mpox Virus DNA Test

EUAs exist under FDA regulation to improve the availability of medical countermeasures, such as vaccines and diagnostic tests, during public health emergencies. With future pandemics a tangible possibility, further EUAs for other PCR tests and vaccines are all but certain.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers